Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fycompa 8mg tablets
0408010AKBBADAD
|
Fycompa | Perampanel | Central Nervous System | 225 |
|
Fycompa 6mg tablets
0408010AKBBACAC
|
Fycompa | Perampanel | Central Nervous System | 197 |
|
Fycompa 2mg tablets
0408010AKBBAAAA
|
Fycompa | Perampanel | Central Nervous System | 186 |
|
Fycompa 10mg tablets
0408010AKBBAEAE
|
Fycompa | Perampanel | Central Nervous System | 167 |
|
Fycompa 4mg tablets
0408010AKBBABAB
|
Fycompa | Perampanel | Central Nervous System | 153 |
|
Fycompa 12mg tablets
0408010AKBBAFAF
|
Fycompa | Perampanel | Central Nervous System | 130 |
|
Fycompa 0.5mg/ml oral suspension
0408010AKBBAGAJ
|
Fycompa | Perampanel | Central Nervous System | 59 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.